SARS-CoV-2 antibody responses in patients with acute leukaemia

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

(2020) Catherine F Houlihan et al.   LANCET

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

(2020) Philip J. M. Brouwer et al.   SCIENCE

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

(2020) Amer M Zeidan et al.   Lancet Haematology

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

(2020) Francesco Passamonti et al.   Lancet Haematology

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

(2020) Lindsey E. Roeker et al.   LEUKEMIA

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

(2020) Suzanne Pickering et al.   PLoS Pathogens

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology